Cost Of Revenue - Devyser Diagnostics AB (STO:DVYSR) - Alpha Spread
D

Devyser Diagnostics AB
STO:DVYSR

Watchlist Manager
Devyser Diagnostics AB
STO:DVYSR
Watchlist
Price: 117.5 SEK 0.43% Market Closed
Market Cap: 1.9B SEK
Have any thoughts about
Devyser Diagnostics AB?
Write Note

Devyser Diagnostics AB
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Devyser Diagnostics AB
Cost of Revenue Peer Comparison

Comparables:
BIOG B
BONEX
VITR
SOBI
BIOA B

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
D
Devyser Diagnostics AB
STO:DVYSR
Cost of Revenue
-kr24.5m
CAGR 3-Years
-9%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Cost of Revenue
-kr346.3m
CAGR 3-Years
-20%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Cost of Revenue
-kr57.2m
CAGR 3-Years
-42%
CAGR 5-Years
-27%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Cost of Revenue
-kr1.5B
CAGR 3-Years
-42%
CAGR 5-Years
-27%
CAGR 10-Years
-26%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Cost of Revenue
-kr5.3B
CAGR 3-Years
-21%
CAGR 5-Years
-14%
CAGR 10-Years
-18%
BioArctic AB
STO:BIOA B
Cost of Revenue
-kr50.9m
CAGR 3-Years
-30%
CAGR 5-Years
-10%
CAGR 10-Years
N/A

See Also

What is Devyser Diagnostics AB's Cost of Revenue?
Cost of Revenue
-24.5m SEK

Based on the financial report for Dec 31, 2023, Devyser Diagnostics AB's Cost of Revenue amounts to -24.5m SEK.

What is Devyser Diagnostics AB's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-10%

Over the last year, the Cost of Revenue growth was -5%. The average annual Cost of Revenue growth rates for Devyser Diagnostics AB have been -9% over the past three years , -10% over the past five years .

Back to Top